(Q40339271)

English

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

scientific article published on May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion (English)

1 reference

Europe PubMed Central

19 September 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Ryosuke Tateishi

7

1 reference

Europe PubMed Central

19 September 2017

author name string

Shuntaro Obi

1

1 reference

Europe PubMed Central

19 September 2017

Haruhiko Yoshida

2

1 reference

Europe PubMed Central

19 September 2017

Risa Toune

3

1 reference

Europe PubMed Central

19 September 2017

Tadao Unuma

4

1 reference

Europe PubMed Central

19 September 2017

Miho Kanda

5

1 reference

Europe PubMed Central

19 September 2017

Shinpei Sato

6

1 reference

Europe PubMed Central

19 September 2017

Takuma Teratani

8

1 reference

Europe PubMed Central

19 September 2017

Shuichiro Shiina

9

1 reference

Europe PubMed Central

19 September 2017

Masao Omata

10

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

106

1 reference

Europe PubMed Central

19 September 2017

1990-1997

1 reference

Europe PubMed Central

19 September 2017

9

1 reference

Europe PubMed Central

19 September 2017

Small hepatocellular carcinoma and cavernous hemangioma: differentiation with dynamic FLASH MR imaging with Gd-DTPA.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

21 January 2018

Portal vein thromboses in malignant hepatoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

21 January 2018

Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 1992

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic arterial embolization for hepatocellular carcinoma. Comparison of CT scans and resected specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiography of small hepatocellular carcinomas: analysis of 105 resected tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamic computed tomography during arterial portography: the most sensitive examination for small hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular Carcinoma and Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor invasiveness and prognosis in resected hepatocellular carcinoma. Clinical and pathogenetic implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrahepatic chemotherapy for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of external radiotherapy in treatment of portal vein invasion in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21832

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21832

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40339271&oldid=2084265665"